Angi, Inc.

As of November 28, 2025, Angi, Inc. is considered overvalued with a P/E ratio of 16, an EV to EBITDA ratio of 8.45, and a Price to Book Value of 0.81, indicating it is less attractive compared to peers like GoodRx Holdings, Inc. with a P/E of 31.76.

As of November 7, 2025, Angi, Inc. is fairly valued with a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, making it more attractive than peers like Sharecare, Inc. and GoodRx Holdings, Inc.

As of November 7, 2025, Angi, Inc. is fairly valued with a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, showing more attractiveness compared to peers and indicating significant growth potential.

As of October 24, 2025, Angi, Inc. shows a mildly bearish technical trend, with mixed signals from MACD and Bollinger Bands across different time frames, despite some short-term strength indicated by daily moving averages.

As of October 24, 2025, Angi, Inc. shows a mildly bearish trend overall, with weekly indicators predominantly bearish despite some mildly bullish signals on the daily timeframe.

As of October 24, 2025, Angi, Inc. shows a mildly bearish technical trend, with bearish signals from the weekly MACD and Bollinger Bands, despite a mildly bullish monthly MACD and daily moving averages.

As of October 17, 2025, Angi, Inc. is considered fairly valued with a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, positioning it competitively against peers like GoodRx and eGain.

As of October 17, 2025, Angi, Inc. is rated as attractive with a P/E ratio of 16, an EV to EBITDA ratio of 8.45, and a Price to Book Value of 0.81, indicating it is fairly valued and potentially undervalued compared to peers like GoodRx Holdings, Inc. and eGain Corp.

As of October 17, 2025, Angi, Inc. is considered attractive and undervalued with a P/E ratio of 16, a price to book value of 0.81, and an EV to EBITDA ratio of 8.45, indicating it trades at a discount compared to peers like GoodRx Holdings, Inc. and eGain Corp.

As of October 10, 2025, Angi, Inc. is considered very attractive and undervalued, with a P/E ratio of 16, an EV to EBITDA of 8.45, and a low PEG ratio of 0.01, making it more appealing compared to peers like GoodRx Holdings, Inc. and EverQuote, Inc.

As of August 26, 2025, Angi, Inc. shows a mildly bullish technical trend supported by positive MACD and moving averages, despite mixed signals from KST and Bollinger Bands.

As of September 3, 2025, Angi, Inc. is considered undervalued with an attractive valuation grade, supported by favorable metrics such as a P/E ratio of 16 and a Price to Book Value of 0.81, especially when compared to peers like GoodRx Holdings, Inc. at 31.76.

As of May 22, 2025, Angi, Inc. is considered an attractive investment due to its undervalued status, with a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45, all indicating it trades below its intrinsic value compared to peers like EverQuote, Inc.

As of June 11, 2025, Angi, Inc. has shifted to a mildly bearish trend, indicated by daily moving averages and mixed monthly signals, despite some mildly bullish weekly indicators.

As of March 2022, the management team of Angi, Inc. includes Chairman Joseph Levin, CEO William Ridenour, Interim CFO Glenn Schiffman, and several directors: Kendall Handler, Craig Smith, Mark Stein, Suzy Welch, and Gregg Winiarski. They oversee the company's operations and strategic direction.

Angi, Inc. operates a digital marketplace connecting homeowners with service professionals in the home services sector. As of March 2025, it reported net sales of $246 million and a net profit of $15 million, with a market cap of $786.40 million.

As of Jun 18, Angi, Inc. has a market capitalization of 786.40 million, with net sales of 1,125.63 million and a net profit of 53.27 million over the latest four quarters.